Etamivan
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Etamivan (INN) or ethamivan (USAN), trade name Analepticon, is a respiratory stimulant drug[1] related to nikethamide. It was mainly used in the treatment of barbiturate overdose[2] and chronic obstructive pulmonary disease,[3] but has now largely fallen into disuse.
References
- ↑ Hirsh K, Wang SC. Respiratory stimulant effects of ethamivan and picrotoxin. Journal of Pharmacology and Experimental Therapeutics. 1975 May;193(2):657-63.
- ↑ Wheeldon PJ, Perry AW. The use of ethamivan in the treatment of barbiturate poisoning. Canadian Medical Association Journal. 1963 Jul 6;89:20-2.
- ↑ Sproule BJ, Jans RL, Breitkreutz H, Mahon W. Effects of ethamivan in patients with chronic respiratory disease. Canadian Medical Association Journal. 1964 Dec 5;91:1203-8.
Template:Stimulants Template:Other respiratory system products
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH